Sep. 16 at 5:30 PM
$AZN $BMY $JNJ $PFE $SLS Part 3.
Yeah. So the initial, you know, assumption was, once the last patient was enrolled, which happened around March of 2024, we expected between 12 to 15 months or so to hit the 80th event.
Obviously, that has surpassed the timing. The reason we're quite excited is really two or three-fold. One is we know the treatment landscape and the behavior of those patients and how they do quite well, again, not only from published literature but from key opinion leaders and real-world evidence.
Ordinarily, the median survival for those patients, it ranges anywhere between, on the low end, six, seven months, and on the high end, maybe around 10, 11 months.
✌️🙏❤️🩹
